Noxopharm investigates Covid-19 treatment

Drug developer Noxopharm is following up on indications that an experimental anti-cancer drug may be effective against the Covid-19 coronavirus. Melbourne’s Hudson Institute of Medical Research has identified anti-inflammatory properties of the experimental drug idronoxil, the active ingredient in the company’s anti-cancer drug candidate Veyonda. Pre-clinical models indicate the drug has the ability to treat…

The reinvention of Australian Industry Content and its ramifications

Australian Manufacturing Forum viewpoint by Mike Kalms Without anything really changing, Australian Industry Content Policy (AICP) is now unalterably different. There have been relatively cosmetic changes to how AICP is described, at what thresholds it applies, and how it might be measured, but none of these constitute wholesale change or any sort of ‘policy re-write’.…

Archer graphite tested in li-ion batteries

Archer Materials has successfully made high-value coated spherical graphite (CSG) from its Campoona graphite mine on South Australia’s Eyre Peninsula and tested it in lithium-ion battery prototypes. The company told investors it had used commercially available amorphous carbon to coat the spherical graphite which was derived from flake graphite mined 220 kilometres north-west of Adelaide.…